Evidence map›Paper›PMID 40401228›Full record

ArticleFrontiers in cardiovascular medicine2025

Case Report: Intragastric balloon placement for weight loss in LVAD patients-a bridge to heart transplantation.

Aarti Desai, Shriya Sharma, Adj Siaw, Jose Ruiz, Victoria Gómez, Rohan Goswami

Abstract readCase Reports
In one paragraph

Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aarti DesaiDivision of Heart Failure and Transplant, Mayo Clinic, Jacksonville, FL, United States.
Shriya SharmaDivision of Heart Failure and Transplant, Mayo Clinic, Jacksonville, FL, United States.
Adj SiawDepartment of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL, United States.
Jose RuizDivision of Heart Failure and Transplant, Mayo Clinic, Jacksonville, FL, United States.
Victoria GómezDepartment of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, United States.
Rohan GoswamiDivision of Heart Failure and Transplant, Mayo Clinic, Jacksonville, FL, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity significantly increases the risk of advanced heart failure, complicating heart transplantation candidacy. Despite aggressive medical therapies, achieving weight loss in these patients remains challenging, especially in patients after durable ventricular assist device (LVAD). More intense weight loss interventions such as bariatric and metabolic surgery and endoscopic bariatric therapies (EBTs) can lead to meaningful weight reduction, enabling previously ineligible individuals to become transplant candidates. A 51-year-old gentleman with end-stage heart and kidney failure status-post HeartMate 3 LVAD (Abbott, Chicago, IL) and Class II obesity (BMI 36.5 kg/m

Indexed as

endoscopic bariatric therapiesheart failureheartMate 3Heart transplantintragastric balloonLVADobesity

Identifiers

PMID40401228
PMCPMC12092439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.